Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 32(34): 11716-26, 2012 Aug 22.
Article in English | MEDLINE | ID: mdl-22915114

ABSTRACT

Activity-dependent modifications of excitatory synapses contribute to synaptic maturation and plasticity, and are critical for learning and memory. Consequently, impairments in synapse formation or synaptic transmission are thought to be responsible for several types of mental disabilities. BRAG1 is a guanine nucleotide exchange factor for the small GTP-binding protein Arf6 that localizes to the postsynaptic density of excitatory synapses. Mutations in BRAG1 have been identified in families with X-linked intellectual disability (XLID). These mutations mapped to either the catalytic domain or an IQ-like motif; however, the pathophysiological basis of these mutations remains unknown. Here, we show that the BRAG1 IQ motif binds apo-calmodulin (CaM), and that calcium-induced CaM release triggers a reversible conformational change in human BRAG1. We demonstrate that BRAG1 activity, stimulated by activation of NMDA-sensitive glutamate receptors, depresses AMPA receptor (AMPA-R)-mediated transmission via JNK-mediated synaptic removal of GluA1-containing AMPA-Rs in rat hippocampal neurons. Importantly, a BRAG1 mutant that fails to activate Arf6 also fails to depress AMPA-R signaling, indicating that Arf6 activity is necessary for this process. Conversely, a mutation in the BRAG1 IQ-like motif that impairs CaM binding results in hyperactivation of Arf6 signaling and constitutive depression of AMPA transmission. Our findings reveal a role for BRAG1 in response to neuronal activity with possible clinical relevance to nonsyndromic XLID.


Subject(s)
ADP-Ribosylation Factors/metabolism , CA1 Region, Hippocampal/cytology , MAP Kinase Signaling System/physiology , Membrane Glycoproteins/metabolism , Neurons/physiology , Presynaptic Terminals/metabolism , Receptors, AMPA/metabolism , Sulfotransferases/metabolism , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/genetics , Amino Acid Motifs/physiology , Animals , Animals, Newborn , Calcium/metabolism , Calmodulin/metabolism , Chelating Agents/pharmacology , Disks Large Homolog 4 Protein , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , HeLa Cells , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Ionomycin/pharmacology , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/genetics , Male , Membrane Glycoproteins/genetics , Membrane Potentials/drug effects , Membrane Potentials/genetics , Membrane Proteins/metabolism , Mutation/physiology , N-Methylaspartate/pharmacology , Neurons/drug effects , Organ Culture Techniques , Patch-Clamp Techniques , Protein Binding , Protein Conformation/drug effects , Rats , Receptors, AMPA/genetics , Sulfotransferases/genetics , Transfection , Valine/analogs & derivatives , Valine/pharmacology
2.
J Biol Chem ; 287(37): 31138-47, 2012 Sep 07.
Article in English | MEDLINE | ID: mdl-22815487

ABSTRACT

ADP ribosylation factors (Arfs) are small GTP-binding proteins known for their role in vesicular transport, where they nucleate the assembly of coat protein complexes at sites of carrier vesicle formation. Similar to other GTPases, Arfs require guanine nucleotide exchange factors to catalyze GTP loading and activation. One subfamily of ArfGEFs, the BRAGs, has been shown to activate Arf6, which acts in the endocytic pathway to control the trafficking of a subset of cargo proteins including integrins. We have previously shown that BRAG2 modulates cell adhesion by regulating integrin surface expression. Here, we show that, in addition to Arf6, endogenous BRAG2 also activates the class II Arfs, Arf4 and Arf5, and that surprisingly, it is Arf5 that mediates integrin internalization. We observed that cell spreading on fibronectin is enhanced upon inhibition of BRAG2 or Arf5 but not Arf6. Similarly, spreading in BRAG2-depleted cells is reverted by expression of a rapid cycling Arf5 mutant (T161A) but not by a corresponding Arf6 construct (T157A). We also show that BRAG2 binds clathrin and the AP-2 adaptor complex and that both BRAG2 and Arf5 localize to clathrin-coated pits at the plasma membrane. Consistent with these observations, depletion of Arf5, but not Arf6 or Arf4, slows internalization of ß1 integrins without affecting transferrin receptor uptake. Together, these findings indicate that BRAG2 acts at clathrin-coated pits to promote integrin internalization by activating Arf5 and suggest a previously unrecognized role for Arf5 in clathrin-mediated endocytosis of specific cargoes.


Subject(s)
ADP-Ribosylation Factors/metabolism , Clathrin/metabolism , Endocytosis/physiology , Guanine Nucleotide Exchange Factors/metabolism , Integrin alpha5beta1/metabolism , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/genetics , Amino Acid Substitution , Cell Adhesion/physiology , Clathrin/genetics , Clathrin-Coated Vesicles/genetics , Clathrin-Coated Vesicles/metabolism , Gene Deletion , Guanine Nucleotide Exchange Factors/genetics , HeLa Cells , Humans , Integrin alpha5beta1/genetics , Mutation, Missense
SELECTION OF CITATIONS
SEARCH DETAIL
...